Next Quarterly Earnings
After-hours — after the market close (typically after 5:30 p.m. CET).
CRISPR Therapeutics is a leading biotechnology company based in Switzerland, specializing in the development of breakthrough gene-editing therapies. By leveraging CRISPR/Cas9 technology, the company addresses serious human diseases through the creation of innovative cell-based therapeutic candidates.
After-hours — after the market close (typically after 5:30 p.m. CET).
CRISPR Therapeutics is scheduled to report its next quarterly earnings on 08/10/2026. After-hours — after the market close (typically after 5:30 p.m. CET).
CRISPR Therapeutics last reported quarterly earnings on 5/4/2026 (Q2 2026). Earnings per share (EPS) came in at -1.28 USD.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.